Covered recipient · General Payments record
JASON VARGHESE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2023
$704.70
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $217.43 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $68.93 | 4 |
| Lilly USA, LLC | $37.05 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $30.51 | 2 |
| GlaxoSmithKline, LLC. | $25.01 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $24.67 | 1 |
| Abbott Laboratories | $16.13 | 1 |
| Acerta Pharma LLC | $15.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.13 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018487171 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.13 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016055889 | CMS |
| Boston Scientific Corporation | $24.67 | 04/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022270099 | CMS |
| GlaxoSmithKline, LLC. | $25.01 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001926405 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $17.01 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034425863 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $13.50 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034425869 | CMS |
| Lilly USA, LLC | $18.17 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031553431 | CMS |
| Lilly USA, LLC | $18.88 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031616201 | CMS |
| Novo Nordisk Inc | $14.80 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002493897 | CMS |
| Novo Nordisk Inc | $20.84 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002493935 | CMS |
| Novo Nordisk Inc | $16.40 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002493911 | CMS |
| Novo Nordisk Inc | $16.89 | 05/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002493923 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.